High Interest in Injectable Opioid Agonist Treatment With Hydromorphone Among Urban Syringe Service Program Participants.
Aaron D FoxLindsey RibackAndres Perez-CorreaEric OhlendorfMegan GhiroliCzarina Navos BehrendsTeresa López-CastroPublished in: Substance use & addiction journal (2024)
SSP participants with OUD reported high interest in iOAT-H. Participants had attempted conventional treatments but still used heroin almost daily. We identified PWID at risk for opioid-related harms who potentially could benefit from iOAT-H.